Medical Pleuroscopy - 02/09/13

Résumé |
There has been an exciting expansion in the practice of medical pleuroscopy in recent years. As technology has become more available and confidence in the use of equipment has grown, medical thoracoscopy has become a core diagnostic and therapeutic tool in pleural disease care. Despite this, many areas of medical pleuroscopy practice remain conspicuously devoid of well-established evidence. More knowledge is needed in those areas where there is currently a degree of equipoise. Many areas where pleuroscopy currently has a marginal role require high-quality randomized trials be undertaken with a view to informing future practice and guidelines.
Le texte complet de cet article est disponible en PDF.Keywords : Pleuroscopy, Thoracoscopy, Pneumothorax, Empyema, Malignant pleural effusions
Plan
| Funding Sources: Dr Bhatnagar has received speaker fees from AstraZeneca and GlaxoSmithKline, and educational grants from Novartis and GlaxoSmithKline. Dr Maskell has received research funding from Novartis and CareFusion. He has also received honoraria from CareFusion for medical advisory board meetings. |
|
| Conflicts of Interest: The authors have no conflicts of interests to declare. |
Vol 34 - N° 3
P. 487-500 - septembre 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
